PHASE CLINICAL SERVICES
LIVE

Serial Number

88625104

Owner

CTH Biotech LLC

First Use Date

Feb 26, 2019

Filing Date

Sep 20, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PHASE CLINICAL SERVICES Trademark

Serial Number: 88625104 • Registration: 6046232

PHASE CLINICAL SERVICES is a trademark filed by CTH Biotech LLC on September 20, 2019. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

CTH Biotech LLC (2 trademarks)

575 LEXINGTON AVE FL 4
New York, NY 10022

Entity Type: 16

Trademark Details

Filing Date

September 20, 2019

Registration Date

May 5, 2020

First Use Anywhere

February 26, 2019

First Use in Commerce

April 4, 2019

Published for Opposition

February 18, 2020

Goods & Services

Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Providing independent review of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs

Providing independent review of clinical trials involving human subjects, namely, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research

Blood analysis services; Scientific and technological services, namely, scientific research in the field of drug development; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others; Conducting clinical trials for others in the field of oncology; Consulting services for others in the field of design, planning, and implementation project management of clinical trials; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Feb 25, 2026 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Feb 25, 2026 8.OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 23, 2026 APRE
TEAS SECTION 8 RECEIVED
Oct 3, 2025 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 5, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
May 5, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 29, 2020 NONP
ASSIGNED TO LIE
Jan 14, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 8, 2020 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2019 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 28, 2019 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2019 NWOS
NEW APPLICATION ENTERED
Sep 24, 2019 NWAP